| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $498.2M | +0.7% |
| Cost of Revenue | $275.3M | -2.7% |
| Gross Profit | $222.9M | +5.4% |
| R&D Expense | $9.4M | -4.0% |
| SG&A Expense | $129.3M | +4.4% |
| Operating Income | $79.8M | +5.8% |
| Pre-tax Income | $70.1M | +3.6% |
| Income Tax | $16.6M | +3.2% |
| Net Income | $53.5M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.5M | -18.7% |
| Accounts Receivable | $109.8M | +2.3% |
| Inventory | $89.0M | +3.1% |
| Current Assets | $274.3M | -0.1% |
| Total Assets | $755.5M | -1.6% |
| Current Liabilities | $112.7M | +3.1% |
| Long-term Debt | $138.9M | -17.1% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.1M | -4.3% |
| Capital Expenditures | $10.2M | -7.0% |
| Investing Cash Flow | -$15.0M | +86.3% |
| Financing Cash Flow | -$56.4M | -199.8% |
| Free Cash Flow | $52.9M | -3.8% |
| +3.7% |
| EPS (Basic) | $1.59 | +3.9% |
| EPS (Diluted) | $1.57 | +4.0% |
| Total Liabilities |
| $260.1M |
| -11.2% |
| Stockholders' Equity | $495.3M | +4.3% |